Acquired Resistance of Lung Adenocarcinomas to Tyrosine Kinase Inhibitors Is Associated with T790M Mutation in the EGFR Kinase Domain

WANG Jie; BAI Xiao-yan

doi:10.3969/j.issn.1671-5144.2008.04.003

WANG Jie, BAI Xiao-yan. Acquired Resistance of Lung Adenocarcinomas to Tyrosine Kinase Inhibitors Is Associated with T790M Mutation in the EGFR Kinase Domain[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 201-204. DOI: 10.3969/j.issn.1671-5144.2008.04.003

Citation:

WANG Jie, BAI Xiao-yan. Acquired Resistance of Lung Adenocarcinomas to Tyrosine Kinase Inhibitors Is Associated with T790M Mutation in the EGFR Kinase Domain[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 201-204. DOI: 10.3969/j.issn.1671-5144.2008.04.003

Citation:

WANG Jie, BAI Xiao-yan. Acquired Resistance of Lung Adenocarcinomas to Tyrosine Kinase Inhibitors Is Associated with T790M Mutation in the EGFR Kinase Domain[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 201-204. DOI: 10.3969/j.issn.1671-5144.2008.04.003

Acquired Resistance of Lung Adenocarcinomas to Tyrosine Kinase Inhibitors Is Associated with T790M Mutation in the EGFR Kinase Domain

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Acquired Resistance of Lung Adenocarcinomas to Tyrosine Kinase Inhibitors Is Associated with T790M Mutation in the EGFR Kinase Domain

Catalog

Export File

Citation

Format

Content